Survey to assess eligibility for neurology clinical trials
Triage Survey for Neurology Research Eligibility
This study is trying to see if people with Alzheimer’s disease can join upcoming neurology clinical trials based on their health and medication use.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 600 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Adams Clinical Research network |
| Locations | 3 sites (Boston, Massachusetts and 2 other locations) |
| Trial ID | NCT06104852 on ClinicalTrials.gov |
What this trial studies
TRIAGE-Neuro is an observational survey designed to evaluate potential participants' eligibility for industry-sponsored neurology clinical trials, specifically targeting individuals with Alzheimer Disease. The study aims to identify participant characteristics, the impact of prescribed memory medications on eligibility, and how changes in these medications affect cognitive assessment performance. Additionally, it will assess laboratory results that may exclude individuals from participation. This comprehensive approach will help streamline the recruitment process for future clinical trials in neurology.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who are interested in participating in neurology clinical trials.
Not a fit: Patients who lack the cognitive ability to understand the screening process or have significant health issues that could impact safety or study results may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the recruitment process for neurology clinical trials, ultimately leading to more effective treatments for Alzheimer Disease.
How similar studies have performed: While this approach is somewhat novel in its focus on eligibility assessment through surveys, similar studies have shown success in improving participant recruitment in clinical trials.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participant and study partner (when applicable) have signed an ICF prior to study-specific procedures being performed. * Participant and study partner (when applicable) are at least 18 years old. Exclusion Criteria: * Participant lacks the language skills or cognitive ability to understand the screening process. * Participant is pregnant, breast-feeding, or planning to become pregnant. * History of a clinically significant illness which in the investigator's opinion may impact participant safety or the ability to analyze study results. * Participant represents an acute suicidal risk, as defined as a "yes" response to ideation on Columbia-Suicide Severity Rating Scale questions 4 or 5, or answer "yes" to behavior questions within 90 days of screening. * Moderate or severe substance use disorder within 90 days prior to screening, according to DSM-5 criteria that in the investigator's opinion could pose undue risk to the participant. * Any condition that in the investigator's opinion makes a participant unsuitable for the study. * Currently employed by Adams Clinical or a first-degree relative of an employee working on this study.
Where this trial is running
Boston, Massachusetts and 2 other locations
- Copley Clinical — Boston, Massachusetts, United States (Not_yet_recruiting)
- Adams Clinical — Watertown, Massachusetts, United States (Recruiting)
- Berman Clinical — New York, New York, United States (Recruiting)
Study contacts
- Study coordinator: Sarah J Starling, PhD
- Email: sstarling@adamsclinical.com
- Phone: 6177448542
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.